All In Biotech

Drug Trial Radar · NCT07613294

A Study to See if Lepodisiran Can Reduce Plaque in Coronary Arteries of Adults With Elevated Lp(a) Who Have Had Heart Events or Are at High Risk

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Trial of Lepodisiran to Investigate the Effect on Coronary Plaque in Adults With Elevated Lp(a) Who Have Established Atherosclerotic Cardiovascular Disease or Are at Risk for a First Cardiovascular Event

Last checked: Nov 20, 2026Latest source record: Nov 4, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. Randomized with 252 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

252

Planned (sponsor's estimate)

Start

Jun 1, 2026

Primary completion

Dec 2029

Study completion Dec 2029

Sponsor

Lead sponsor
Eli Lilly and CompanyEli Lilly (LLY)
Sponsor type
Industry
First posted
May 29, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 45 years, up to 80 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Lipoprotein(a), also known as Lp(a), is a protein that carries cholesterol and proteins in your blood. People with high Lp(a) have a higher risk for heart disease. The main purpose of the study is to investigate how lepodisiran, compared to a placebo, affects the amount and type of plaque in the heart's vessels using an imaging technology known as Coronary Computed Tomography Angiography (CCTA) in adults who have high levels of Lp(a). Participation will last about 120 weeks.

Conditions

  • Atherosclerosis
  • Cardiovascular Diseases
  • Lipoprotein(a)

Interventions

  • LepodisiranDrug

    Administered SC

  • PlaceboDrug

    Administered SC

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Percent Change from Baseline in Noncalcified Plaque (NCP) VolumeTime frame: Baseline, Week 104

Locations

57 sites in 7 countries. Site status is shown where the registry gives one.

  • UCSD - Altman Clinical and Translational Research Institute (ACTRI)

    La Jolla, California · Recruiting

  • Valley Clinical Trials, Inc.

    Northridge, California · Recruiting

  • Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center

    Torrance, California · Recruiting

  • Jellinger and Lerman, MD PA dba The Center for Diabetes and Endocrine Care

    Fort Lauderdale, Florida · Recruiting

  • Jacksonville Center for Clinical Research

    Jacksonville, Florida · Recruiting

  • Merritt Island Medical Research, LLC

    Merritt Island, Florida · Recruiting

  • Inpatient Research Clinic

    Miami Lakes, Florida · Recruiting

  • Clinical Site Partners, LLC dba Flourish Research

    Winter Park, Florida · Recruiting

  • High Desert Heart & Vascular

    Meridian, Idaho · Recruiting

  • Massachusetts General Hospital

    Boston, Massachusetts · Not yet recruiting

  • Profound Research LLC

    Farmington Hills, Michigan · Recruiting

  • Vector Clinical Trials

    Las Vegas, Nevada · Recruiting

  • Heart and Vascular Research at WellSpan Health

    York, Pennsylvania · Recruiting

  • Intermountain Medical Center

    Murray, Utah · Recruiting

  • Virginia Heart

    Falls Church, Virginia · Recruiting

  • Carilion Clinic

    Roanoke, Virginia · Recruiting

  • Eastside Research Associates

    Redmond, Washington · Recruiting

  • Nightingale Research

    Adelaide, Australia · Recruiting

  • University of the Sunshine Coast (UniSC) Clinical Trials - Birtinya

    Birtinya, Australia · Recruiting

  • Core Research Group

    Brisbane, Australia · Recruiting

  • Advara HeartCare - Burwood

    Burwood, Australia · Recruiting

  • Advara HeartCare Joondalup

    Joondalup, Australia · Recruiting

  • Advara HeartCare Leabrook

    Leabrook, Australia · Recruiting

  • AIM Research

    Merewether, Australia · Recruiting

  • USC Clinical Trials Brisbane (South Bank)

    South Brisbane, Australia · Recruiting

  • Clinitrials

    West Perth, Australia · Recruiting

  • Fakultni Nemocnice u sv. Anny v Brne

    Brno, Czechia · Recruiting

  • EFERTUS healthcare s.r.o.

    Brno, Czechia · Recruiting

  • Top Moravia Health

    Brno, Czechia · Recruiting

  • Fakultni Nemocnice u sv. Anny v Brne

    Brno, Czechia · Recruiting

  • Óbudai Egészségügyi Centrum

    Budapest, Hungary · Recruiting

  • Semmelweis University

    Budapest, Hungary · Recruiting

  • Szabolcs Szatmár Bereg Vármegyei Oktatókórház

    Nyíregyháza, Hungary · Recruiting

  • Medisch Spectrum Twente

    Enschede, Netherlands · Recruiting

  • Ziekenhuis St. Jansdal

    Harderwijk, Netherlands · Not yet recruiting

  • Alrijne Ziekenhuis, locatie Leiderdorp

    Leiderdorp, Netherlands · Not yet recruiting

  • VieCuri Medisch Centrum, locatie Venlo

    Venlo, Netherlands · Not yet recruiting

  • CHUAC-Complejo Hospitalario Universitario A Coruña

    A Coruña, Spain · Recruiting

  • Parc de Salut Mar - Hospital del Mar

    Barcelona, Spain · Recruiting

  • Hospital Quiron Barcelona

    Barcelona, Spain · Recruiting

Showing 40 of 57 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.